<?xml version="1.0"?><rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2022, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Tue, 11 Jan 2022 09:09:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Life Science Alliance journal publishes results of plitidepsin in patients with COVID-19, which includes additional data on its antiviral activity against Delta and Omicron variants</title>
   <link>http://www.streetinsider.com/Press+Releases/Life+Science+Alliance+journal+publishes+results+of+plitidepsin+in+patients+with+COVID-19%2C+which+includes+additional+data+on+its+antiviral+activity+against+Delta+and+Omicron+variants/19446715.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Life+Science+Alliance+journal+publishes+results+of+plitidepsin+in+patients+with+COVID-19%2C+which+includes+additional+data+on+its+antiviral+activity+against+Delta+and+Omicron+variants/19446715.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Life+Science+Alliance+journal+publishes+results+of+plitidepsin+in+patients+with+COVID-19%2C+which+includes+additional+data+on+its+antiviral+activity+against+Delta+and+Omicron+variants/19446715.html</guid>
   <pubDate>Tue, 11 Jan 2022 09:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">0RC6</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHMMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	  </item>
  <item>
   <title>Life Science Alliance journal publishes results of plitidepsin in patients with COVID-19, which includes additional data on its antiviral activity against Delta and Omicron variants</title>
   <link>http://www.streetinsider.com/Press+Releases/Life+Science+Alliance+journal+publishes+results+of+plitidepsin+in+patients+with+COVID-19%2C+which+includes+additional+data+on+its+antiviral+activity+against+Delta+and+Omicron+variants/19446715.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Life+Science+Alliance+journal+publishes+results+of+plitidepsin+in+patients+with+COVID-19%2C+which+includes+additional+data+on+its+antiviral+activity+against+Delta+and+Omicron+variants/19446715.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Life+Science+Alliance+journal+publishes+results+of+plitidepsin+in+patients+with+COVID-19%2C+which+includes+additional+data+on+its+antiviral+activity+against+Delta+and+Omicron+variants/19446715.html</guid>
   <pubDate>Tue, 11 Jan 2022 09:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">0RC6</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHMMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	  </item>
  <item>
   <title>Life Science Alliance journal publishes results of plitidepsin in patients with COVID-19, which includes additional data on its antiviral activity against Delta and Omicron variants</title>
   <link>http://www.streetinsider.com/Press+Releases/Life+Science+Alliance+journal+publishes+results+of+plitidepsin+in+patients+with+COVID-19%2C+which+includes+additional+data+on+its+antiviral+activity+against+Delta+and+Omicron+variants/19446715.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Life+Science+Alliance+journal+publishes+results+of+plitidepsin+in+patients+with+COVID-19%2C+which+includes+additional+data+on+its+antiviral+activity+against+Delta+and+Omicron+variants/19446715.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Life+Science+Alliance+journal+publishes+results+of+plitidepsin+in+patients+with+COVID-19%2C+which+includes+additional+data+on+its+antiviral+activity+against+Delta+and+Omicron+variants/19446715.html</guid>
   <pubDate>Tue, 11 Jan 2022 09:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">0RC6</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHMMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	  </item>
  <item>
   <title>Life Science Alliance journal publishes results of plitidepsin in patients with COVID-19, which includes additional data on its antiviral activity against Delta and Omicron variants</title>
   <link>http://www.streetinsider.com/Press+Releases/Life+Science+Alliance+journal+publishes+results+of+plitidepsin+in+patients+with+COVID-19%2C+which+includes+additional+data+on+its+antiviral+activity+against+Delta+and+Omicron+variants/19446715.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Life+Science+Alliance+journal+publishes+results+of+plitidepsin+in+patients+with+COVID-19%2C+which+includes+additional+data+on+its+antiviral+activity+against+Delta+and+Omicron+variants/19446715.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Life+Science+Alliance+journal+publishes+results+of+plitidepsin+in+patients+with+COVID-19%2C+which+includes+additional+data+on+its+antiviral+activity+against+Delta+and+Omicron+variants/19446715.html</guid>
   <pubDate>Tue, 11 Jan 2022 09:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">0RC6</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHMMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	  </item>
  <item>
   <title>Life Science Alliance journal publishes results of plitidepsin in patients with COVID-19, which includes additional data on its antiviral activity against Delta and Omicron variants</title>
   <link>http://www.streetinsider.com/Press+Releases/Life+Science+Alliance+journal+publishes+results+of+plitidepsin+in+patients+with+COVID-19%2C+which+includes+additional+data+on+its+antiviral+activity+against+Delta+and+Omicron+variants/19446715.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Life+Science+Alliance+journal+publishes+results+of+plitidepsin+in+patients+with+COVID-19%2C+which+includes+additional+data+on+its+antiviral+activity+against+Delta+and+Omicron+variants/19446715.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Life+Science+Alliance+journal+publishes+results+of+plitidepsin+in+patients+with+COVID-19%2C+which+includes+additional+data+on+its+antiviral+activity+against+Delta+and+Omicron+variants/19446715.html</guid>
   <pubDate>Tue, 11 Jan 2022 09:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">0RC6</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHMMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	  </item>
  <item>
   <title>Life Science Alliance journal publishes results of plitidepsin in patients with COVID-19, which includes additional data on its antiviral activity against Delta and Omicron variants</title>
   <link>http://www.streetinsider.com/Press+Releases/Life+Science+Alliance+journal+publishes+results+of+plitidepsin+in+patients+with+COVID-19%2C+which+includes+additional+data+on+its+antiviral+activity+against+Delta+and+Omicron+variants/19446715.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Life+Science+Alliance+journal+publishes+results+of+plitidepsin+in+patients+with+COVID-19%2C+which+includes+additional+data+on+its+antiviral+activity+against+Delta+and+Omicron+variants/19446715.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Life+Science+Alliance+journal+publishes+results+of+plitidepsin+in+patients+with+COVID-19%2C+which+includes+additional+data+on+its+antiviral+activity+against+Delta+and+Omicron+variants/19446715.html</guid>
   <pubDate>Tue, 11 Jan 2022 09:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">0RC6</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHMMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	  </item>
  <item>
   <title>Life Science Alliance journal publishes results of plitidepsin in patients with COVID-19, which includes additional data on its antiviral activity against Delta and Omicron variants</title>
   <link>http://www.streetinsider.com/Press+Releases/Life+Science+Alliance+journal+publishes+results+of+plitidepsin+in+patients+with+COVID-19%2C+which+includes+additional+data+on+its+antiviral+activity+against+Delta+and+Omicron+variants/19446715.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Life+Science+Alliance+journal+publishes+results+of+plitidepsin+in+patients+with+COVID-19%2C+which+includes+additional+data+on+its+antiviral+activity+against+Delta+and+Omicron+variants/19446715.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Life+Science+Alliance+journal+publishes+results+of+plitidepsin+in+patients+with+COVID-19%2C+which+includes+additional+data+on+its+antiviral+activity+against+Delta+and+Omicron+variants/19446715.html</guid>
   <pubDate>Tue, 11 Jan 2022 09:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">0RC6</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHMMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	  </item>
  <item>
   <title>Life Science Alliance journal publishes results of plitidepsin in patients with COVID-19, which includes additional data on its antiviral activity against Delta and Omicron variants</title>
   <link>http://www.streetinsider.com/PRNewswire/Life+Science+Alliance+journal+publishes+results+of+plitidepsin+in+patients+with+COVID-19%2C+which+includes+additional+data+on+its+antiviral+activity+against+Delta+and+Omicron+variants/19446715.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Life+Science+Alliance+journal+publishes+results+of+plitidepsin+in+patients+with+COVID-19%2C+which+includes+additional+data+on+its+antiviral+activity+against+Delta+and+Omicron+variants/19446715.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Life+Science+Alliance+journal+publishes+results+of+plitidepsin+in+patients+with+COVID-19%2C+which+includes+additional+data+on+its+antiviral+activity+against+Delta+and+Omicron+variants/19446715.html</guid>
   <pubDate>Tue, 11 Jan 2022 09:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">0RC6</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHMMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	  </item>
  <item>
   <title>Life Science Alliance journal publishes results of plitidepsin in patients with COVID-19, which includes additional data on its antiviral activity against Delta and Omicron variants</title>
   <link>http://www.streetinsider.com/PRNewswire/Life+Science+Alliance+journal+publishes+results+of+plitidepsin+in+patients+with+COVID-19%2C+which+includes+additional+data+on+its+antiviral+activity+against+Delta+and+Omicron+variants/19446715.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Life+Science+Alliance+journal+publishes+results+of+plitidepsin+in+patients+with+COVID-19%2C+which+includes+additional+data+on+its+antiviral+activity+against+Delta+and+Omicron+variants/19446715.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Life+Science+Alliance+journal+publishes+results+of+plitidepsin+in+patients+with+COVID-19%2C+which+includes+additional+data+on+its+antiviral+activity+against+Delta+and+Omicron+variants/19446715.html</guid>
   <pubDate>Tue, 11 Jan 2022 09:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">0RC6</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHMMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	  </item>
  <item>
   <title>Life Science Alliance journal publishes results of plitidepsin in patients with COVID-19, which includes additional data on its antiviral activity against Delta and Omicron variants</title>
   <link>http://www.streetinsider.com/PRNewswire/Life+Science+Alliance+journal+publishes+results+of+plitidepsin+in+patients+with+COVID-19%2C+which+includes+additional+data+on+its+antiviral+activity+against+Delta+and+Omicron+variants/19446715.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Life+Science+Alliance+journal+publishes+results+of+plitidepsin+in+patients+with+COVID-19%2C+which+includes+additional+data+on+its+antiviral+activity+against+Delta+and+Omicron+variants/19446715.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Life+Science+Alliance+journal+publishes+results+of+plitidepsin+in+patients+with+COVID-19%2C+which+includes+additional+data+on+its+antiviral+activity+against+Delta+and+Omicron+variants/19446715.html</guid>
   <pubDate>Tue, 11 Jan 2022 09:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">0RC6</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHMMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	  </item>
  <item>
   <title>Life Science Alliance journal publishes results of plitidepsin in patients with COVID-19, which includes additional data on its antiviral activity against Delta and Omicron variants</title>
   <link>http://www.streetinsider.com/PRNewswire/Life+Science+Alliance+journal+publishes+results+of+plitidepsin+in+patients+with+COVID-19%2C+which+includes+additional+data+on+its+antiviral+activity+against+Delta+and+Omicron+variants/19446715.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Life+Science+Alliance+journal+publishes+results+of+plitidepsin+in+patients+with+COVID-19%2C+which+includes+additional+data+on+its+antiviral+activity+against+Delta+and+Omicron+variants/19446715.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Life+Science+Alliance+journal+publishes+results+of+plitidepsin+in+patients+with+COVID-19%2C+which+includes+additional+data+on+its+antiviral+activity+against+Delta+and+Omicron+variants/19446715.html</guid>
   <pubDate>Tue, 11 Jan 2022 09:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">0RC6</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHMMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	  </item>
  <item>
   <title>Life Science Alliance journal publishes results of plitidepsin in patients with COVID-19, which includes additional data on its antiviral activity against Delta and Omicron variants</title>
   <link>http://www.streetinsider.com/PRNewswire/Life+Science+Alliance+journal+publishes+results+of+plitidepsin+in+patients+with+COVID-19%2C+which+includes+additional+data+on+its+antiviral+activity+against+Delta+and+Omicron+variants/19446715.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Life+Science+Alliance+journal+publishes+results+of+plitidepsin+in+patients+with+COVID-19%2C+which+includes+additional+data+on+its+antiviral+activity+against+Delta+and+Omicron+variants/19446715.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Life+Science+Alliance+journal+publishes+results+of+plitidepsin+in+patients+with+COVID-19%2C+which+includes+additional+data+on+its+antiviral+activity+against+Delta+and+Omicron+variants/19446715.html</guid>
   <pubDate>Tue, 11 Jan 2022 09:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">0RC6</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHMMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	  </item>
  <item>
   <title>Life Science Alliance journal publishes results of plitidepsin in patients with COVID-19, which includes additional data on its antiviral activity against Delta and Omicron variants</title>
   <link>http://www.streetinsider.com/PRNewswire/Life+Science+Alliance+journal+publishes+results+of+plitidepsin+in+patients+with+COVID-19%2C+which+includes+additional+data+on+its+antiviral+activity+against+Delta+and+Omicron+variants/19446715.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Life+Science+Alliance+journal+publishes+results+of+plitidepsin+in+patients+with+COVID-19%2C+which+includes+additional+data+on+its+antiviral+activity+against+Delta+and+Omicron+variants/19446715.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Life+Science+Alliance+journal+publishes+results+of+plitidepsin+in+patients+with+COVID-19%2C+which+includes+additional+data+on+its+antiviral+activity+against+Delta+and+Omicron+variants/19446715.html</guid>
   <pubDate>Tue, 11 Jan 2022 09:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">0RC6</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHMMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	  </item>
  <item>
   <title>Life Science Alliance journal publishes results of plitidepsin in patients with COVID-19, which includes additional data on its antiviral activity against Delta and Omicron variants</title>
   <link>http://www.streetinsider.com/PRNewswire/Life+Science+Alliance+journal+publishes+results+of+plitidepsin+in+patients+with+COVID-19%2C+which+includes+additional+data+on+its+antiviral+activity+against+Delta+and+Omicron+variants/19446715.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Life+Science+Alliance+journal+publishes+results+of+plitidepsin+in+patients+with+COVID-19%2C+which+includes+additional+data+on+its+antiviral+activity+against+Delta+and+Omicron+variants/19446715.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Life+Science+Alliance+journal+publishes+results+of+plitidepsin+in+patients+with+COVID-19%2C+which+includes+additional+data+on+its+antiviral+activity+against+Delta+and+Omicron+variants/19446715.html</guid>
   <pubDate>Tue, 11 Jan 2022 09:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">0RC6</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHMMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	  </item>
  <item>
   <title>PharmaMar Has Announced That the Spanish Medicines Agency Has Authorized the APLICOV-PC Clinical Trial With Aplidin® (Plitidepsin) for the Treatment of Patients With COVID-19</title>
   <link>http://www.streetinsider.com/Press+Releases/PharmaMar+Has+Announced+That+the+Spanish+Medicines+Agency+Has+Authorized+the+APLICOV-PC+Clinical+Trial+With+Aplidin%C2%AE+%28Plitidepsin%29+for+the+Treatment+of+Patients+With+COVID-19/16794009.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/PharmaMar+Has+Announced+That+the+Spanish+Medicines+Agency+Has+Authorized+the+APLICOV-PC+Clinical+Trial+With+Aplidin%C2%AE+%28Plitidepsin%29+for+the+Treatment+of+Patients+With+COVID-19/16794009.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/PharmaMar+Has+Announced+That+the+Spanish+Medicines+Agency+Has+Authorized+the+APLICOV-PC+Clinical+Trial+With+Aplidin%C2%AE+%28Plitidepsin%29+for+the+Treatment+of+Patients+With+COVID-19/16794009.html</guid>
   <pubDate>Tue, 28 Apr 2020 06:35:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">0RC6</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06210439</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHMMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	  </item>
  <item>
   <title>PharmaMar Has Announced That the Spanish Medicines Agency Has Authorized the APLICOV-PC Clinical Trial With Aplidin® (Plitidepsin) for the Treatment of Patients With COVID-19</title>
   <link>http://www.streetinsider.com/Press+Releases/PharmaMar+Has+Announced+That+the+Spanish+Medicines+Agency+Has+Authorized+the+APLICOV-PC+Clinical+Trial+With+Aplidin%C2%AE+%28Plitidepsin%29+for+the+Treatment+of+Patients+With+COVID-19/16794009.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/PharmaMar+Has+Announced+That+the+Spanish+Medicines+Agency+Has+Authorized+the+APLICOV-PC+Clinical+Trial+With+Aplidin%C2%AE+%28Plitidepsin%29+for+the+Treatment+of+Patients+With+COVID-19/16794009.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/PharmaMar+Has+Announced+That+the+Spanish+Medicines+Agency+Has+Authorized+the+APLICOV-PC+Clinical+Trial+With+Aplidin%C2%AE+%28Plitidepsin%29+for+the+Treatment+of+Patients+With+COVID-19/16794009.html</guid>
   <pubDate>Tue, 28 Apr 2020 06:35:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">0RC6</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06210439</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHMMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	  </item>
  <item>
   <title>PharmaMar Has Announced That the Spanish Medicines Agency Has Authorized the APLICOV-PC Clinical Trial With Aplidin® (Plitidepsin) for the Treatment of Patients With COVID-19</title>
   <link>http://www.streetinsider.com/Press+Releases/PharmaMar+Has+Announced+That+the+Spanish+Medicines+Agency+Has+Authorized+the+APLICOV-PC+Clinical+Trial+With+Aplidin%C2%AE+%28Plitidepsin%29+for+the+Treatment+of+Patients+With+COVID-19/16794009.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/PharmaMar+Has+Announced+That+the+Spanish+Medicines+Agency+Has+Authorized+the+APLICOV-PC+Clinical+Trial+With+Aplidin%C2%AE+%28Plitidepsin%29+for+the+Treatment+of+Patients+With+COVID-19/16794009.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/PharmaMar+Has+Announced+That+the+Spanish+Medicines+Agency+Has+Authorized+the+APLICOV-PC+Clinical+Trial+With+Aplidin%C2%AE+%28Plitidepsin%29+for+the+Treatment+of+Patients+With+COVID-19/16794009.html</guid>
   <pubDate>Tue, 28 Apr 2020 06:35:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">0RC6</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06210439</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHMMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	  </item>
  <item>
   <title>PharmaMar Has Announced That the Spanish Medicines Agency Has Authorized the APLICOV-PC Clinical Trial With Aplidin® (Plitidepsin) for the Treatment of Patients With COVID-19</title>
   <link>http://www.streetinsider.com/Press+Releases/PharmaMar+Has+Announced+That+the+Spanish+Medicines+Agency+Has+Authorized+the+APLICOV-PC+Clinical+Trial+With+Aplidin%C2%AE+%28Plitidepsin%29+for+the+Treatment+of+Patients+With+COVID-19/16794009.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/PharmaMar+Has+Announced+That+the+Spanish+Medicines+Agency+Has+Authorized+the+APLICOV-PC+Clinical+Trial+With+Aplidin%C2%AE+%28Plitidepsin%29+for+the+Treatment+of+Patients+With+COVID-19/16794009.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/PharmaMar+Has+Announced+That+the+Spanish+Medicines+Agency+Has+Authorized+the+APLICOV-PC+Clinical+Trial+With+Aplidin%C2%AE+%28Plitidepsin%29+for+the+Treatment+of+Patients+With+COVID-19/16794009.html</guid>
   <pubDate>Tue, 28 Apr 2020 06:35:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">0RC6</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06210439</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHMMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	  </item>
  <item>
   <title>PharmaMar Has Announced That the Spanish Medicines Agency Has Authorized the APLICOV-PC Clinical Trial With Aplidin® (Plitidepsin) for the Treatment of Patients With COVID-19</title>
   <link>http://www.streetinsider.com/Press+Releases/PharmaMar+Has+Announced+That+the+Spanish+Medicines+Agency+Has+Authorized+the+APLICOV-PC+Clinical+Trial+With+Aplidin%C2%AE+%28Plitidepsin%29+for+the+Treatment+of+Patients+With+COVID-19/16794009.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/PharmaMar+Has+Announced+That+the+Spanish+Medicines+Agency+Has+Authorized+the+APLICOV-PC+Clinical+Trial+With+Aplidin%C2%AE+%28Plitidepsin%29+for+the+Treatment+of+Patients+With+COVID-19/16794009.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/PharmaMar+Has+Announced+That+the+Spanish+Medicines+Agency+Has+Authorized+the+APLICOV-PC+Clinical+Trial+With+Aplidin%C2%AE+%28Plitidepsin%29+for+the+Treatment+of+Patients+With+COVID-19/16794009.html</guid>
   <pubDate>Tue, 28 Apr 2020 06:35:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">0RC6</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06210439</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHMMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	  </item>
  <item>
   <title>PharmaMar Has Announced That the Spanish Medicines Agency Has Authorized the APLICOV-PC Clinical Trial With Aplidin® (Plitidepsin) for the Treatment of Patients With COVID-19</title>
   <link>http://www.streetinsider.com/Press+Releases/PharmaMar+Has+Announced+That+the+Spanish+Medicines+Agency+Has+Authorized+the+APLICOV-PC+Clinical+Trial+With+Aplidin%C2%AE+%28Plitidepsin%29+for+the+Treatment+of+Patients+With+COVID-19/16794009.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/PharmaMar+Has+Announced+That+the+Spanish+Medicines+Agency+Has+Authorized+the+APLICOV-PC+Clinical+Trial+With+Aplidin%C2%AE+%28Plitidepsin%29+for+the+Treatment+of+Patients+With+COVID-19/16794009.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/PharmaMar+Has+Announced+That+the+Spanish+Medicines+Agency+Has+Authorized+the+APLICOV-PC+Clinical+Trial+With+Aplidin%C2%AE+%28Plitidepsin%29+for+the+Treatment+of+Patients+With+COVID-19/16794009.html</guid>
   <pubDate>Tue, 28 Apr 2020 06:35:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">0RC6</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06210439</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHMMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	  </item>
  <item>
   <title>PharmaMar Has Announced That the Spanish Medicines Agency Has Authorized the APLICOV-PC Clinical Trial With Aplidin® (Plitidepsin) for the Treatment of Patients With COVID-19</title>
   <link>http://www.streetinsider.com/Press+Releases/PharmaMar+Has+Announced+That+the+Spanish+Medicines+Agency+Has+Authorized+the+APLICOV-PC+Clinical+Trial+With+Aplidin%C2%AE+%28Plitidepsin%29+for+the+Treatment+of+Patients+With+COVID-19/16794009.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/PharmaMar+Has+Announced+That+the+Spanish+Medicines+Agency+Has+Authorized+the+APLICOV-PC+Clinical+Trial+With+Aplidin%C2%AE+%28Plitidepsin%29+for+the+Treatment+of+Patients+With+COVID-19/16794009.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/PharmaMar+Has+Announced+That+the+Spanish+Medicines+Agency+Has+Authorized+the+APLICOV-PC+Clinical+Trial+With+Aplidin%C2%AE+%28Plitidepsin%29+for+the+Treatment+of+Patients+With+COVID-19/16794009.html</guid>
   <pubDate>Tue, 28 Apr 2020 06:35:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">0RC6</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06210439</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHMMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	  </item>
  <item>
   <title>PharmaMar Has Announced That the Spanish Medicines Agency Has Authorized the APLICOV-PC Clinical Trial With Aplidin® (Plitidepsin) for the Treatment of Patients With COVID-19</title>
   <link>http://www.streetinsider.com/Press+Releases/PharmaMar+Has+Announced+That+the+Spanish+Medicines+Agency+Has+Authorized+the+APLICOV-PC+Clinical+Trial+With+Aplidin%C2%AE+%28Plitidepsin%29+for+the+Treatment+of+Patients+With+COVID-19/16794009.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/PharmaMar+Has+Announced+That+the+Spanish+Medicines+Agency+Has+Authorized+the+APLICOV-PC+Clinical+Trial+With+Aplidin%C2%AE+%28Plitidepsin%29+for+the+Treatment+of+Patients+With+COVID-19/16794009.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/PharmaMar+Has+Announced+That+the+Spanish+Medicines+Agency+Has+Authorized+the+APLICOV-PC+Clinical+Trial+With+Aplidin%C2%AE+%28Plitidepsin%29+for+the+Treatment+of+Patients+With+COVID-19/16794009.html</guid>
   <pubDate>Tue, 28 Apr 2020 06:35:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">0RC6</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06210439</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHMMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	  </item>
  <item>
   <title>PharmaMar Has Announced That the Spanish Medicines Agency Has Authorized the APLICOV-PC Clinical Trial With Aplidin® (Plitidepsin) for the Treatment of Patients With COVID-19</title>
   <link>http://www.streetinsider.com/PRNewswire/PharmaMar+Has+Announced+That+the+Spanish+Medicines+Agency+Has+Authorized+the+APLICOV-PC+Clinical+Trial+With+Aplidin%C2%AE+%28Plitidepsin%29+for+the+Treatment+of+Patients+With+COVID-19/16794009.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/PharmaMar+Has+Announced+That+the+Spanish+Medicines+Agency+Has+Authorized+the+APLICOV-PC+Clinical+Trial+With+Aplidin%C2%AE+%28Plitidepsin%29+for+the+Treatment+of+Patients+With+COVID-19/16794009.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/PharmaMar+Has+Announced+That+the+Spanish+Medicines+Agency+Has+Authorized+the+APLICOV-PC+Clinical+Trial+With+Aplidin%C2%AE+%28Plitidepsin%29+for+the+Treatment+of+Patients+With+COVID-19/16794009.html</guid>
   <pubDate>Tue, 28 Apr 2020 06:35:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">0RC6</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06210439</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHMMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	  </item>
  <item>
   <title>PharmaMar Has Announced That the Spanish Medicines Agency Has Authorized the APLICOV-PC Clinical Trial With Aplidin® (Plitidepsin) for the Treatment of Patients With COVID-19</title>
   <link>http://www.streetinsider.com/PRNewswire/PharmaMar+Has+Announced+That+the+Spanish+Medicines+Agency+Has+Authorized+the+APLICOV-PC+Clinical+Trial+With+Aplidin%C2%AE+%28Plitidepsin%29+for+the+Treatment+of+Patients+With+COVID-19/16794009.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/PharmaMar+Has+Announced+That+the+Spanish+Medicines+Agency+Has+Authorized+the+APLICOV-PC+Clinical+Trial+With+Aplidin%C2%AE+%28Plitidepsin%29+for+the+Treatment+of+Patients+With+COVID-19/16794009.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/PharmaMar+Has+Announced+That+the+Spanish+Medicines+Agency+Has+Authorized+the+APLICOV-PC+Clinical+Trial+With+Aplidin%C2%AE+%28Plitidepsin%29+for+the+Treatment+of+Patients+With+COVID-19/16794009.html</guid>
   <pubDate>Tue, 28 Apr 2020 06:35:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">0RC6</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06210439</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHMMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	  </item>
  <item>
   <title>PharmaMar Has Announced That the Spanish Medicines Agency Has Authorized the APLICOV-PC Clinical Trial With Aplidin® (Plitidepsin) for the Treatment of Patients With COVID-19</title>
   <link>http://www.streetinsider.com/PRNewswire/PharmaMar+Has+Announced+That+the+Spanish+Medicines+Agency+Has+Authorized+the+APLICOV-PC+Clinical+Trial+With+Aplidin%C2%AE+%28Plitidepsin%29+for+the+Treatment+of+Patients+With+COVID-19/16794009.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/PharmaMar+Has+Announced+That+the+Spanish+Medicines+Agency+Has+Authorized+the+APLICOV-PC+Clinical+Trial+With+Aplidin%C2%AE+%28Plitidepsin%29+for+the+Treatment+of+Patients+With+COVID-19/16794009.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/PharmaMar+Has+Announced+That+the+Spanish+Medicines+Agency+Has+Authorized+the+APLICOV-PC+Clinical+Trial+With+Aplidin%C2%AE+%28Plitidepsin%29+for+the+Treatment+of+Patients+With+COVID-19/16794009.html</guid>
   <pubDate>Tue, 28 Apr 2020 06:35:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">0RC6</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06210439</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHMMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PMR</category>
   	  </item>
 </channel>
</rss>
